Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS. “AIDS vaccine development
Read moreResearchers at the Buck Institute analyzed data from the COVID-19 Symptom Tracker app used by 3 million people in the United Kingdom, adding the use
Read moreThe Food and Drug Administration has granted emergency use authorization for a new COVID-19 vaccine developed by Janssen Pharmaceuticals Inc., a subsidiary of Johnson &
Read moreA new substance could improve the treatment of persistent cancers. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Greifswald have developed a
Read moreAs the global population ages, the rate of dementia is increasing worldwide. Given that early detection is critical for treatment, effective ways to screen for
Read moreJorge Figueroa was willing to drive eight hours round trip. He wasn’t going on vacation or to visit a relative. Instead, he was planning to
Read moreGlycine can stimulate or inhibit neurons in the brain, thereby controlling complex functions. Unraveling the three-dimensional structure of the glycine transporter, researchers have now come
Read moreOne of the hallmarks of chronic pain is inflammation, and scientists at the UNC School of Medicine have discovered that anti-inflammatory cells called MRC1+ macrophages
Read moreNew technology from Purdue University innovators may help improve tissue restoration outcomes for people with breast cancer and other diseases or traumatic injuries. Purdue researchers,
Read moreBiologists from RUDN University confirmed that a well-known spasmolytic drug called hymecromone can suppress the inflammatory response in astrocytes, important glial cells of the central
Read more